Self-StudyCo-Occurring Conditions
You are just a few steps away from free CE credits!
Sign in or Register
A free account is required.
Study the Material
An entire Cc section, or just a few topics at a time.
Take the CE Quiz
5 questions covering the topics in each Cc section.
Claim CE Credit
Free CNE and Free CME available!
- Lesson 5 Overview
Hepatitis B Coinfection - 0%Topic 1
BackgroundActivities- 0%Topic 2
Screening for HBV in Persons with HIVActivities- 0%Topic 3
Initial Evaluation of Persons with HBV and HIV CoinfectionActivities- 0%Topic 4
Treatment of HBV and HIV in Persons with HIV and HBV CoinfectionActivities- 0%Topic 5
Monitoring HBV Treatment ResponseActivities- 0%Topic 6
Management of HIV or HBV Virologic FailureActivities- 0%Topic 7
Stopping HBV Treatment and Hepatic FlaresActivities- 0%Topic 8
HBV-Related Immune Reconstitution Syndrome (HBV-IRIS)Activities- 0%Topic 9
Hepatitis D VirusActivities- 0%Topic 10
Preventing HBV Perinatal TransmissionActivities- 0%Topic 11
Surveillance for Hepatocellular CarcinomaHepatitis B Coinfection Overview
About this Lesson
Last Updated: April 6th, 2024CNE/CME Continuing Education
This lesson qualifies for:- 1.5 CME AMA PRA Category 1 Credits™, or
- 1.5 CNE contact hours and 1.5 CE contact hours (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: October 1st, 2017CNE and CME Review: September 1st, 2023CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE3rd Edition
This is a substantial revision of the original Lesson. The previous edition was titled Hepatitis B Coinfection and available until September 1st, 2023.Learning Objectives
- Identify appropriate tests for evaluation of hepatitis B virus (HBV) infection and immunity
- Summarize the approach to persons with HIV who have isolated hepatitis B core antibody
- Discuss antiretroviral management of persons with HIV and HBV coinfection
- Describe HBV-related immune reconstitution syndrome
- List indications and methods for hepatocellular carcinoma surveillance in persons with chronic HBV and HIV coinfection
Lesson Contributors
Authors
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneDavid H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
Aley G. Kalapila, MD, PhDAley G. Kalapila, MD, PhD
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health SystemDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Question Bank
Interactive board-review style questions about Epidemiology of HIV.
CNE/CME CME+MOC credits and CNE contact hours available.
Requires sign-in for CE credit or Certificates
Funded byHealth Resources and Services Administration (HRSA)Created at University of WashingtonAn AETC ProgramPart of IDEA PlatformCME provided byUniversity of Alabama BirminghamCNE provided byUniversity of Washington School of NursingCopyright © 2024 National HIV CurriculumThe National HIV Curriculum is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $1,172,990 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.govSince you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhivc-master-a3460488-2024-11-13-205621 - 0%Topic 2